References
Charlton B, AunchiclossJr H, Fathman CG (1994) Mechanisms of transplantation tolerance. Annu Rev Immunol: 707-734.
Waldmann TA (1992) Immune receptors: Targets for therapy of leukemia/lymphoma, autoimmune diseases and for the prevention of allograft rejection. Annu Rev Immunol 10: 675-704.
Kenyon NS, Strasser S and Alejandro R (1990) Ultraviolet light immunomodulation of canine islets for prolongation of allograft survival. Diabetes 39(3): 305-311.
Alejandro R, Latif Z, Noel J et al. (1987) Effect of anti-Ia antibodies, culture and cyclosporin on prolongation of canine islet allograft survival. Diabetes 36(3): 269-273.
Billingham RE, Brent L and Medawar PB (1953) Actively acquired tolerance of foreign cells. Nature 172: 603-606.
Billingham RE and Brent L (1954) Quantitative studies of tissue transplantation immunity. II. The origins, strength and duration of actively and adoptively acquired immunity. Proc R Soc B 143: 58-80.
Lee S and Fisher B (1961) Portocaval shunt in the rat. Surgery 50: 668-673.
Fabre JW, Lim SH and Morris PJ (1971) Renal transplantation in the rat: Details of a technique. Aust NZ J Surgery 41: 69-75.
Stuart FP, Saitoh T and Fitch FW (1968) Rejection of renal allografts: Specific immunologic suppression. Science 160: 1463-1465.
French ME and Batchelor JR (1969) Immunological enhancement of rat kidney grafts. Lancet 2: 1103-1106.
Opelz G, Sengar DPS, Mickey MRet al. (1973) Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 5: 253-259.
De Waal LP and Van Twuyver E (1991) Blood transfusions and allograft survival: Is mixed chimerism the solution for tolerance induction in clinical transplantation? Crit Rev Immunol 10: 417-425.
Thomas JM, Carver FM, Cunningham PR et al. (1991) Kidney allograft tolerance in primates without chronic immunosuppression - the role of veto cells. Transplantation 51: 198-207.
Thomas JM, Carver FM, Kasten-Jolly J et al. (1994) Further studies of veto activity in rhesus monkey bone marrow in relation to allograft tolerance and chimerism. Transplantation 57: 101-115.
Thomas JM, Verbanac KM and Thomas FT (1991) The veto mechanism in transplant tolerance. Transplantation Rev 5: 209-229.
Kaufman CL, Colson YL, Wren SM et al. (1994) Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood 84(8): 2436-2446.
Monaco AP, Wood ML and Russel PS (1966) Studies on heterologous anti-lymphocyte serum in mice: III. Immunologic tolerance and chimerism produced across the H-2 locus with adult thymectomy and anti-lymphocyte serum. Ann NY Acad Sci 129: 190-206.
Hartner WC, DeFazio SR, Maki T et al. (1986) Prolongation of renal allograft survival in antilymphocyte-serumtreated dogs by postoperative injection of density-gradientfractionated donor bone marrow. Transplantation 42(6): 593-597.
Monaco AP, Clark Aw, Wood ML et al. (1976) Possible active enhancement of a human cadaver renal allograft with antilymphocytic serum (ALS) and donor bone marrow: Case report of an initial attempt. Surgery 79: 384-392.
McDaniel DO, Naftilan J, Hulvey K et al. (1994) Peripheral blood chimerism in renal allograft recipients transfused with donor bone marrow. Transplantation 57: 852-856.
Stewart FM, Crittenden RB, Lowry PA et al. (1993) Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal mice. Blood 81: 2566-2571.
Harrison DE (1993) Competitive repopulation in unirradiated normal recipients. Blood 81: 2473-2474.
Starzl TE, Demetris AJ, Trucco M et al. (1993) Chimerism and donor specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation 55: 1272-1277.
Starzl TE, Demetris AJ, Murase N et al. (1993) Donor cell chimerism permitted by immunosuppressive drugs: a probable basis of organ transplant acceptance and tolerance. Immunology Today 14: 326-332.
Ricordi C, Ildstad ST, Demetris AJ et al. (1992) Donor dendritic cells repopulation in recipients after rat-to-mouse bone marrow transplantation. Lancet 339: 1610-1611.
Ricordi C, Ildstad ST and Starzl Te (1992) Induction of pancreatic islet graft acceptance: The role of antigen presenting cells. Transplantation Science 2: 34-38.
Ricordi C, Tzakis AG, Demetris AJ et al. (1993) Reversal of graft-versus-host disease with infusion of stored autologous bonemarrowcells following combined liver-bone marrow allo-transplantation in man. Transplantation Science 3: 76-77.
Ricordi C, Tzakis Ag, Zeevi A et al. (1994) Reversal of graftverus-host disease with infusion of autologous bone marrow. Cell Transplant 3: 187-192.
Fontes P, Rao A, Demetris AJ et al. (1994) Augmentation with bone marrow of donor leukocyte migration for kidney, liver, heart, and pancreas islet transplantation. Lancet 344: 151-155.
Brendel M, Kong SS, Schachner RD et al. (1995) The effect of donor specific vertebral body derived bone marrow cell infusion on islet allograft survival in the dog without cytoablative conditioning of the recipient. Presented at the International Symposium on Tolerance Induction, Breckenridge, Colorado, Jan 22-25.
Ricordi C, Karatzas T, Selvaggi G et al. (1995) Multiple bone marrow infusions to enhance acceptance of allografts from the same donor. Ann NY Acad Sci: in press.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kenyon, N.S., Ricordi, C. Hematopoietic cell transplantation for tolerance induction. Cytotechnology 26, 1–4 (1998). https://doi.org/10.1023/A:1007902711633
Issue Date:
DOI: https://doi.org/10.1023/A:1007902711633